CompanyDeals

HKEX 2022 Annual Report: IPO Activity Declines Amid Global Challenges

CompanyDrug

Konruns Initiates Phase II Study for KC1036 in Advanced Thymic Tumors

CompanyDrug

Dizal’s Sunvozertinib NDA Accepted for Review by China’s NMPA

CompanyDrug

HighTide Therapeutics Doses First Patient in Phase IIb Study for HTD1801 in NASH

Drug

MSD Submits Initial Quotation for Molnupiravir in China Amid New COVID-19 Rules

CompanyDrug

Treadwell Therapeutics’ CFI-402257 Granted Fast-Track Status by FDA

Policy / Regulatory

CDE Releases 66th Batch of Chemical Generic Reference Preparations

CompanyDrug

Jiangsu Kanion’s KYS202002A Greenlit for Clinical Study in Multiple Myeloma

CompanyDeals

Gaoling Medical Secures Funding for Infrared Thermotherapy Technology

CompanyDrug

Yiling Pharmaceutical’s BIO-008 Accepted for Review by China’s NMPA

CompanyDeals

Sino Biopharmaceutical Secures Rights to Biosimilar of Amgen’s Xgeva in China

CompanyDeals

CanSino Biologics to Issue GDRs on SWX Swiss Exchange to Boost Globalization